Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Leading the Charge toward Advancing Research on Treatments for Primary and Metastatic Central Nervous System Cancers

CNS Pharmaceuticals is a clinical stage biotechnology company focused on the development of novel treatments for brain tumors The company’s lead product candidate, Berubicin, is a novel anthracycline that is designed to cross the blood-brain barrier The blood-brain barrier ordinarily hinders the vascular delivery of therapeutic substances to brain tumors By crossing this protective barrier, […]

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) of Portfolio Companies Increasing Plant-based Food Production Capacity, Retail Outlets

Eat Well Investment Group Inc. is an investor and rapidly growing producer of nutritious plant-based foods Eat Well recently announced that its Belle Pulses subsidiary is increasing its legumes-based protein output capacity in response to global concerns about the food supply chain in the wake of the COVID pandemic and Russia’s war on Ukraine Russia […]

Cepton, Inc. (NASDAQ: CPTN) Poised to Increase Visibility in Autonomous Driving as Lidar Technology Strives to Dominate the Space

Cepton continues to be at forefront of state-of-the-art engineering science; sponsors The AutoDrive Challenge(TM) II and serves as an exclusive LiDAR supplier During this competition, faculty members and students from ten North American universities will spend four years developing autonomous vehicles that require no human interaction in their operations Participating teams will work with directional […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.